Hyundai Motor Co. has announced to recall its 883,000 Sonata sedan cars from 2011-2014 model years due to gear shifting problems.
South Korea's largest automaker says that while the vehicle is in motion it might happen that the transmission lever might not be able to display the correct gear position. Even if the driver stops the car and puts the transmission in "park" the car may still gear and roll away.
According to documents posted on Wednesday at the U. S. National Highway Traffic Safety Administration's website, there is revelation of problems that can lead to the risk of collision and can cause injuries to the drivers, passengers and pedestrians. Drivers may find issues while starting the car as they won't be able to the transmission it into parking mode.
Hyundai claims to have been received with nearly 1,171 warranty claims. However, they have not yet figured to point out any accidents or injuries relating to this defect.
The Sonata is Hyundai's second-best-selling vehicle in the U. S. behind the Elantra. It represents 29 % of all new Hyundai sales in the U. S. in the first half of the year, or 106,347 units.
After notifying the owners by letter between now and the end of September, Hyundai dealers will inspect the shift cables and repair their connection if it's required.
Owners with questions can call Hyundai customer service at (800) 633-5151.
In its annual Environmental Responsibility Report for fiscal year 2015 released last Thursday, tech giant Apple has revealed that nearly 90 million pounds of unwanted or broken electronics were processed by the company over the last one year....
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
There are a lot of things not going right at the IRS and...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).